1 | | 11-KETOTESTOSTERONE 3-CMO | 11-KETOTESTOSTERONE 3-CMO | C21H29NO5
| | |
2 | 347850-26-4 | PDE4 inhibitor intermediate 1 | PDE4 inhibitor intermediate 1 | C21H29NO5
| | |
3 | | 11BETA-HYDROXYANDROSTENDIONE-3-O-CMO | 11BETA-HYDROXYANDROSTENDIONE-3-O-CMO | C21H29NO5
| | |
4 | | 4-ANDROSTEN-3,19-DIONE-17BETA-OL-19-CMO | 4-ANDROSTEN-3,19-DIONE-17BETA-OL-19-CMO | C21H29NO5
| | |
5 | | 4-ANDROSTEN-17BETA-OL-3,6-DIONE 6-O-CARBOXYMETHYLOXIME | 4-ANDROSTEN-17BETA-OL-3,6-DIONE 6-O-CARBOXYMETHYLOXIME | C21H29NO5
| | |
6 | | 5-ANDROSTEN-3BETA-OL-7,17-DIONE 7-CARBOXYMETHYLOXIME BSA | 5-ANDROSTEN-3BETA-OL-7,17-DIONE 7-CARBOXYMETHYLOXIME BSA | C21H29NO5
| | |
7 | | 4-ANDROSTEN-17BETA-OL-3,15-DIONE 15-CARBOXYMETHYLOXIME:BSA | 4-ANDROSTEN-17BETA-OL-3,15-DIONE 15-CARBOXYMETHYLOXIME:BSA | C21H29NO5
| | |
8 | | 5-ANDROSTEN-3-BETA-OL-7,17-DIONE 7-CARBOXYMETHYLOXIME : BSA | 5-ANDROSTEN-3-BETA-OL-7,17-DIONE 7-CARBOXYMETHYLOXIME : BSA | C21H29NO5
| | |
9 | | 17-hydroxyandrost-4-ene-3,15-dione-15-(O-carboxymethyl)oxime | 17-hydroxyandrost-4-ene-3,15-dione-15-(O-carboxymethyl)oxime | C21H29NO5
| | |
10 | 225377-55-9 | 叔丁基(R)-3-((S )-4苄基-2-恶唑烷酮-3羰基))己酸酯 | (R)-tert-butyl 3-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)hexanoate | C21H29NO5
| | |
11 | 898782-07-5 | 乙基 5-[4-[8-(1,4-二恶-8-氮杂螺-[4.5]癸基)甲基]苯基]-5-羰基戊酸酯 | ethyl 5-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | C21H29NO5
| | |
12 | 724454-57-3 | 4-acetyl-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-octyl-1,5-dihydro-2H-pyrrol-2-one | 4-acetyl-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-octyl-1,5-dihydro-2H-pyrrol-2-one | C21H29NO5
| | |
13 | 898127-35-0 | 4-acetyl-1-(2-ethylhexyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1,5-dihydro-2H-pyrrol-2-one | 4-acetyl-1-(2-ethylhexyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1,5-dihydro-2H-pyrrol-2-one | C21H29NO5
| | |
14 | 1160247-48-2 | 2-(1-(叔-丁氧羰基)-6-甲氧基-2,3-二氢螺[茚并-1,4-哌啶]-3-基)乙酸 | 2-(1-(Tert-Butoxycarbonyl)-6-Methoxy-2,3-Dihydrospiro[Indene-1,4-Piperidine]-3-Yl)Acetic Acid(WX105053) | C21H29NO5
| | |